Anthony Letai

ORCID: 0000-0002-1993-9013

Also affiliated with Dana-Farber Brigham Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 32 papers. Top paper: “The landscape of somatic copy-number alteration across human cancers”.

The landscape of somatic copy-number alteration across human cancers

Nature(2010)10.1038/nature08822

N/A

1.2DataRank · unranked

4101 citations

Craig H. Mermel, Dale A. Porter, Guo Wei, Soumya Raychaudhuri, Jerry Donovan +61 more

Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML

Blood Advances(2024)10.1182/bloodadvances.2023012120

N/A

1.2DataRank · unranked

46 citations

Haesook T. Kim, H. Moses Murdock, Michela Ansuinelli, Jennifer Brock, Corey Cutler +18 more

Activation of Notch and Myc Signaling via B-cell–Restricted Depletion of Dnmt3a Generates a Consistent Murine Model of Chronic Lymphocytic Leukemia

Cancer Research(2021)10.1158/0008-5472.can-21-1273

N/A

0.749DataRank · unranked

22 citations

Shanye Yin, Helene Kretzmer, Elisa Ten Hacken, Salma Parvin, Fabienne Lucas +26 more

High-throughput dynamic BH3 profiling may quickly and accurately predict effective therapies in solid tumors

Science Signaling(2020)10.1126/scisignal.aay1451

N/A

0.637DataRank · unranked

69 citations

Eman Y. Ahmed, Jennifer L. Guerriero, Ewa Sicińska, Emily Su, Elizaveta Lavrova +14 more

An Autochthonous Mouse Model of Myd88 - and BCL2 -Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities

Blood Cancer Discovery(2020)10.1158/2643-3230.bcd-19-0059

N/A

0DataRank · unranked

38 citations

Tim Rehkämper, Pascal Nieper, Pauline Pfeiffer, Alessandra Holzem, Sebastian Klein +33 more

Leukemia cell of origin influences apoptotic priming and sensitivity to LSD1 inhibition

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.11.089060

N/A

0DataRank · unranked

7 citations

S. Haihua Chu, Aaron D. Goldberg, Salma Parvin, Richard P. Koche, Jacob L. Glass +22 more

Use of Murine Models to Identify Tumor Immune Components that Correlate with Response to Immunotherapy in Breast Cancer

Research Square(2020)10.21203/rs.3.rs-57679/v1

N/A

0DataRank · unranked

0 citations

Anita K. Mehta, Emily Cheney, Eric P. Miller, Alaba Sotayo, Elizabeth A. Mittendorf +3 more

Functional precision oncology: Testing tumors with drugs to identify vulnerabilities and novel combinations

Cancer Cell(2021)10.1016/j.ccell.2021.12.004

N/A

0DataRank · unranked

285 citations

Patrick Bhola, Alana L. Welm, Anthony Letai

An In Vivo CRISPR Screening Platform for Prioritizing Therapeutic Targets in AML

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1851

N/A

0DataRank · unranked

78 citations

Clément Larrue, Nastassja K. Scheidegger, Bo Kyung A. Seong, Neekesh V. Dharia, Miljan Kuljanin +17 more

Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening

Cancer Discovery(2021)10.1158/2159-8290.cd-20-0872

N/A

0DataRank · unranked

47 citations

David Requena, Lavoisier Ramos‐Espiritu, Denise Ng, Patrick Bhola, Ype P. de Jong +31 more

Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer

Breast Cancer Research(2021)10.1186/s13058-021-01448-1

N/A

0DataRank · unranked

18 citations

Madeline G Townsend, Anita K. Mehta, Madisson Oliwa, Eric D. Miller, Alaba Sotayo +5 more

Death in the Fas, ELANE

Cell(2021)10.1016/j.cell.2021.05.024

N/A

0DataRank · unranked

5 citations

Anthony Letai

Co-deletion of ATAD1 with PTEN primes cells for BIM-mediated apoptosis

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.07.01.450781

N/A

0DataRank · unranked

5 citations

Heidi L. Fresenius, Heather R. Keys, Corey N. Cunningham, Jeremy Ryan, Deepika Sirohi +9 more

Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer

Research Square(2021)10.21203/rs.3.rs-57679/v2

N/A

0DataRank · unranked

2 citations

Anita K. Mehta, Madeline G Townsend, Madisson Oliwa, Eric D. Miller, Alaba Sotayo +5 more

Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia

Signal Transduction and Targeted Therapy(2022)10.1038/s41392-021-00870-3

N/A

0DataRank · unranked

186 citations

Bridget Riley‐Gillis, Lina Han, Yannan Jia, Alessia Lodi, Haijiao Zhang +36 more

JAK3 mutations and mitochondrial apoptosis resistance in T-cell acute lymphoblastic leukemia

Leukemia(2022)10.1038/s41375-022-01558-5

N/A

0DataRank · unranked

23 citations

Natsuko Yamagata, Anais Barthe, Jack Landrigan, Tríona Ní Chonghaile, Melissa Burns +11 more

Collateral deletion of the mitochondrial AAA+ ATPase ATAD1 sensitizes cancer cells to proteasome dysfunction

eLife(2022)10.7554/elife.82860

N/A

0DataRank · unranked

20 citations

Heidi L. Fresenius, Corey N. Cunningham, Peng Wei, Heather R. Keys, Jordan A. Berg +12 more

Author Correction: Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma

Leukemia(2022)10.1038/s41375-022-01588-z

N/A

0DataRank · unranked

0 citations

Shruti Bhatt, Kenneth Wen, Zuzana Chyra, Geoffrey Fell, Yu‐Tzu Tai +7 more

Heterogeneity and transcriptional drivers of triple-negative breast cancer

Cell Reports(2023)10.1016/j.celrep.2023.113564

N/A

0DataRank · unranked

29 citations

Daniel Temko, Laura E. Stevens, Marco Seehawer, Anne Fassl, Katherine C. Murphy +33 more

Dynamic BH3 profiling identifies pro-apoptotic drug combinations for the treatment of malignant pleural mesothelioma

Nature Communications(2023)10.1038/s41467-023-38552-z

N/A

0DataRank · unranked

23 citations

Ruochen Du, Stephan Bohl, Kin-Hoe Chow, Keith L. Ligon, Raphael Bueno +2 more

BH3 profiling identifies BCL-2 dependence in adult patients with early T-cell progenitor acute lymphoblastic leukemia

Blood Advances(2023)10.1182/bloodadvances.2022007728

N/A

0DataRank · unranked

14 citations

Karanpreet Singh Bhatia, Aarthi N. Mahesh, Shazwina Rosli, Jameelah S. Mohamed, Wei‐Ying Jen +8 more

BH3 profiling as pharmacodynamic biomarker for the activity of BH3 mimetics

Haematologica(2023)10.3324/haematol.2023.283060

N/A

0DataRank · unranked

6 citations

Youzhen Wang, Shumei Qiu, Mariana Villalobos-Ortiz, Jeremy Ryan, Erick Morris +3 more

Data from Activation of Notch and Myc Signaling via B-cell–Restricted Depletion of Dnmt3a Generates a Consistent Murine Model of Chronic Lymphocytic Leukemia

(2023)10.1158/0008-5472.c.6513540.v1

N/A

0DataRank · unranked

0 citations

Shanye Yin, Helene Kretzmer, Elisa Ten Hacken, Salma Parvin, Fabienne Lucas +26 more

Data from Preclinical Modeling of Leiomyosarcoma Identifies Susceptibility to Transcriptional CDK Inhibitors through Antagonism of E2F-Driven Oncogenic Gene Expression

(2023)10.1158/1078-0432.c.6532647.v1

N/A

0DataRank · unranked

0 citations

Patrick Bhola, Michael A. Loycano, Justin A. Anderson, Madeleine L. Taddei, Leona A. Doyle +11 more

Data from Preclinical Modeling of Leiomyosarcoma Identifies Susceptibility to Transcriptional CDK Inhibitors through Antagonism of E2F-Driven Oncogenic Gene Expression

(2023)10.1158/1078-0432.c.6532647

N/A

0DataRank · unranked

0 citations

Patrick Bhola, Michael A. Loycano, Justin A. Anderson, Madeleine L. Taddei, Leona A. Doyle +11 more

Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts

Blood Cancer Discovery(2024)10.1158/2643-3230.bcd-24-0001

N/A

0DataRank · unranked

11 citations

Karanpreet Singh Bhatia, Chuqi Wang, Marissa S. Pioso, Xiao Xian Lin, Ahmed M. Mamdouh +18 more

Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphoma

Leukemia(2025)10.1038/s41375-025-02697-1

N/A

0DataRank · unranked

4 citations

Felix Korell, Irene Scarfò, Caroline R.M. Wiggers, Allen Basanthakumar, Zachary Eisenbies +13 more

Dynamic BH3 profiling predicts clinical outcomes in acute myeloid leukemia

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.14.682414

N/A

0DataRank · unranked

0 citations

Leah Krotee, Jason Wu, Lindsey Thornton, Geoffrey Fell, Sonja Herter +19 more

Venetoclax/FluBu2 RIC transplant followed by all-oral venetoclax/decitabine maintenance for poor-risk MDS/AML

Blood Advances(2025)10.1182/bloodadvances.2025018631

N/A

0DataRank · unranked

0 citations

Haesook T. Kim, H. Moses Murdock, Anna Bosch, Kevin M. Panaro, Felicia Lim +20 more

Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid Leukemia

Cancer Cell(2020)10.1016/j.ccell.2020.10.010

N/A

0DataRank · unranked

177 citations

Marissa S. Pioso, Elyse A. Olesinski, Binyam Yilma, Jeremy Ryan, Thelma Mashaka +18 more

Aneuploidy increases resistance to chemotherapeutics by antagonizing cell division

Proceedings of the National Academy of Sciences(2020)10.1073/pnas.2009506117

N/A

0DataRank · unranked

119 citations

Wen Zhou, Adrianna E. Amaro, James M. McFarland, Mariana Villalobos-Ortiz, Jeremy Ryan +7 more

Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypes

Blood Advances(2020)10.1182/bloodadvances.2020002580

N/A

0DataRank · unranked

53 citations

Regan E. Stephenson, Raymond Reynolds, Shivem B. Shah, Rishi Puri, Scott D. Butler +13 more